The use of Benicar has been linked to sprue-like enteropathy and other gastrointestinal issues.
In August 2017, a $300 million settlement was reached with the manufacturer of Benicar on behalf of individuals who filed lawsuits after suffering sprue-like enteropathy and other gastrointestinal issues from Benicar, Benicar HCT, Azor and Tribenzor.
Below are the news stories and videos we have posted on this topic, including the details of the lawsuits that were filed.